期刊文献+

关于头孢哌酮与丁胺卡那霉素治疗急性肾盂肾炎的比较分析 预览

Comparative analysis of cefoperazone and amikacin in the treatment of acute pyelonephritis
在线阅读 下载PDF
收藏 分享 导出
摘要 目的比较头孢哌酮与丁胺卡那霉素治疗急性肾盂肾炎的临床疗效。方法选取2016年5月~2018年4月我院收治的96例急性肾盂肾炎患者,按照随机数字表法将其分为对照组(48例)和研究组(48例),对照组予以丁胺卡那霉素注射液静脉滴注,研究组予以头孢哌酮注射液静脉滴注,并比较不同组患者临床疗效、尿培养转阴率以及不良反应发生率。结果研究组患者临床治疗总有效率以及尿培养转阴率均高于对照组,但两组比较差异不显著(P>0.05);研究组患者不良反应发生率显著低于对照组,两组比较差异显著(P<0.05)。结论丁胺卡那霉素和头孢哌酮治疗急性肾盂肾炎疗效相当,但后者不良反应发生率更少. Objective To compare the clinical efficacy of cefoperazone and amikacin in the treatment of acute pyelonephritis. Methods 96 patients with acute pyelonephritis admitted to our hospital from May 2016 to April 2018 were randomly divided into the control group (48 cases) and the study group (48 cases).The control group received amikacin.Intravenous infusion of natamycin injection,the study group was given intravenous infusion of cefoperazone injection,and the clinical efficacy,urine culture conversion rate and adverse reaction rate of different groups were compared. Results The total effective rate of clinical treatment and the negative rate of urine culture in the study group were higher than those in the control group, but the difference between the two groups was not significant ( P > 0.05).The incidence of adverse reactions in the study group was significantly lower than that in the control group.Significant ( P < 0.05). Conclusion Amikacin and cefoperazone are equally effective in the treatment of acute pyelonephritis, but the latter has a lower incidence of adverse reactions.
作者 朱胜保 ZHU Sheng-bao(Department of Nephrology, Liqun Hospital,Putuo District,Shanghai,Shanghai 200333,China)
出处 《临床医药文献电子杂志》 2019年第8期10-11,共2页 Journal of Clinicl Medical Literature ( Electronic Edition )
关键词 丁胺卡那霉素 头孢哌酮 急性肾盂肾炎 临床疗效 Amikacin Cefoperazone Acute pyelonephritis Clinical efficacy
  • 相关文献

参考文献7

二级参考文献29

共引文献20

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈